Trial intelligence / Profile preview

ECT response prediction and cognitive side-effect reduction with rivastigmine

2020-005633-33Phase 4Active

Sponsor

University Medical Center Groningen

Start

Mar 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1